Drugs / Purified Vero Rabies Vaccine Serum Free
Purified Vero Rabies Vaccine Serum Free
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01930357 | Sep 2013 → Aug 2014 | rabies | Sanofi Pasteur, a Sanofi Company | Completed | Met primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purified Vero Rabies Vaccine Serum Free | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01930357 ↗ |
| Known as | PVRV-NG | “A serum-free, highly purified Vero rabies vaccine (PVRV-NG) has been developed with no animal or human components and low residual DNA content.” PMID 35906106 ↗ Jul 2022 |
| Known as | VRVg | “Participants will receive receive 3 vaccinations of Purified Vero Rabies Vaccine Serum Free (VRVg)” NCT01930357 ↗ |
| Modality | Vaccine | “A serum-free, highly purified Vero rabies vaccine (PVRV-NG) has been developed with no animal or human components and low residual DNA content.” PMID 35906106 ↗ Jul 2022 |
| Route | Intramuscular | “0.5 mL, Intramuscular (Day 0, Day 7 and Day 28).” NCT01930357 ↗ |